Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$33.32 - $42.1 $793,382 - $1 Million
23,811 Added 79.2%
53,877 $1.99 Million
Q3 2023

Nov 09, 2023

BUY
$36.46 - $44.03 $1.1 Million - $1.32 Million
30,066 New
30,066 $1.15 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Wafra Inc. Portfolio

Follow Wafra Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wafra Inc. with notifications on news.